Sweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups
NCT07587918 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-05-14
Summary
Chronic kidney disease (CKD) is a common condition and a major global cause of illness and mortality. The most common cause of kidney damage is diabetes, a condition that disrupts metabolism, leading to increased risk of damage to the kidneys and blood vessels. There is evidence suggesting that a diet with high acid load - consisting of acid-forming foods such as meat, cheese, and grain products - may contribute to this damage. People with such a diet often have poorer blood sugar control and more kidney damage. However, it is not yet well understood whether reducing dietary acid load can improve kidney function and diabetes management. Additionally, the role of ethnicity and sex in this process remains insufficiently explored.
The goal of this clinical trial is to understand how diet affects kidney function and blood sugar regulation in individuals with diabetes type 2 and chronic kidney disease, as well as to explore the role of sex and ethnicity in these effects. The main questions it aims to answer are:
Does a diet with lower acid load (e.g. less meat, cheese, and grain products) improve kidney function and blood sugar regulation in people with diabetes type 2 and chronic kidney disease?
Does the effect of diet on kidney function and blood sugar differ between ethnic groups, specifically between White-Dutch and South-Asian Surinamese descent people?
Participants will:
* be randomly assigned to follow either a high- or low-acid load diet for 8 weeks;
* Visit the study center four times (including screening)
* Complete food diaries three times per week and keep in regular contact with a dietitian;
* Collect 2x24-hour urine samples and morning feces at each visit ;
* Undergo blood sampling and an oral glucose tolerance test (OGTT).
* Spend a total of 8 hours at the study center (2 visits of 3 hours for OGTT and body composition tests, and 2 visits of 1 hour for additional assessments);
* Have up to 200 ml of blood collected during the study.
Conditions
Interventions
- OTHER
-
Low Dietary Acid Load
This arm will follow a DAL lowering diet with the aim to reach \<25mEq H⁺/day
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Ilias Attaye, Dr. · Erasmus Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2028-06-01
- Completion
- 2028-06-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Tryptophan Metabolism in Kidney Disease
NCT00758537 ·Status: COMPLETED
-
An Observational Study of Patients With Chronic Kidney Disease
NCT05774392 ·Status: WITHDRAWN
-
A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05004428 ·Status: COMPLETED
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
NCT01364779 ·Status: COMPLETED
-
Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus
NCT05342545 ·Status: COMPLETED ·Phase: NA
-
A Study of Drug-Induced Kidney Disease
NCT00729014 ·Status: UNKNOWN
-
Stress and CKD Among African Americans
NCT03387319 ·Status: COMPLETED ·Phase: NA
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
L-Arginine, Symmetrical and Asymmetrical Dimethylarginine (SDMA/ADMA) in Acute Kidney Injury (AKI)
NCT01552525 ·Status: COMPLETED
-
The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease
NCT01589705 ·Status: TERMINATED
-
Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
NCT00364884 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
NCT00507052 ·Status: UNKNOWN ·Phase: NA
-
Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney Disease
NCT01769963 ·Status: COMPLETED ·Phase: NA
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Safe Kidney Care Cohort Study
NCT01407367 ·Status: COMPLETED
-
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
NCT05193981 ·Status: ACTIVE_NOT_RECRUITING
-
Intrarenal Microvasculature in ADPKD
NCT05288998 ·Status: ACTIVE_NOT_RECRUITING
-
Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)
NCT01415570 ·Status: UNKNOWN
-
Insulin Resistance, Sarcopenia and Plasma BAIBA Levels
NCT04309201 ·Status: COMPLETED
-
Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
NCT05735093 ·Status: UNKNOWN
-
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy
NCT05695573 ·Status: COMPLETED
-
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
NCT00304148 ·Status: ACTIVE_NOT_RECRUITING
-
ADMA Levels in End-Stage Renal Disease
NCT00350974 ·Status: COMPLETED
-
Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT00912704 ·Status: COMPLETED